Stockholm, Sweden

Luke Benjamin Pase

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Luke Benjamin Pase: Pioneering T-cell Research

Introduction

Luke Benjamin Pase, an accomplished inventor based in Stockholm, Sweden, has made significant contributions to the field of immunology. With a total of three patents to his name, he is recognized for his innovative approaches to understanding and enhancing T-cell functionality.

Latest Patents

His latest patent features an engineered multi-component system designed for the identification and characterization of T-cell receptors and T-cell antigens. The invention involves a multicomponent system comprising an engineered antigen-presenting cell (eAPC), referred to as component A, alongside a genetic donor vector, designated component C. This innovative setup enables the delivery of open reading frames (ORFs) encoding an analyte antigen-presenting complex (aAPX) and/or an analyte antigenic molecule (aAM). Notably, component A lacks endogenous surface expression of specific antigen-presenting complexes while incorporating two genomic receiver sites for the integration of the essential ORFs.

Career Highlights

Luke Benjamin Pase's career is marked by his dedication to advancing immunological research through patentable innovations. His work at Genovie AB, a company focused on cutting-edge scientific developments, further solidifies his status as an influential inventor in the biomedical field.

Collaborations

Luke has collaborated with notable colleagues, including Reagan Micheal Jarvis and Ryan Edward Hill, who share a commitment to driving innovation in T-cell research. These partnerships have contributed to a vibrant exchange of ideas and methodologies, enhancing the overall impact of their collective work.

Conclusion

In summary, Luke Benjamin Pase stands out in the realm of scientific invention, particularly in T-cell research. His patented innovations not only reflect his expertise but also pave the way for future advancements that could significantly influence therapeutic approaches in immunology. His ongoing efforts at Genovie AB promise continued contributions to science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…